secwatch.observer — SEC 8-K summary
======================================

Issuer:     CANNAPHARMARX, INC. (CPMD)
CIK:        0001081938
Form:       8-K
Filed at:   2025-03-31T23:59:59+00:00
Accession:  0001654954-25-003608
Event type: leadership
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

CannaPharmaRX appoints Constantine Nkafu as interim CEO, adds two directors
---------------------------------------------------------------------------

- Constantine Nkafu appointed interim CEO and board member; has led operations for past several months.
- Elliot Zemel appointed to board; holds Health Canada authorization for director role.
- Adam Mindle was previously designated but decided not to pursue Health Canada approval, never became director.
- Board now consists of Richard Orman, Dominic Colvin, Anthony Michael Panek, Nkafu, and Zemel.
- Nkafu receives $97,000 annual salary through subsidiary employment agreement with 2323414 Alberta Ltd.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1081938/000165495425003608/0001654954-25-003608-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1081938/000165495425003608/canna_8k.htm
  HTML page:      https://secwatch.observer/filing/0001654954-25-003608

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer